DOUBLE-BLIND PLACEBO-CONTROLLED STUDY OF LORATADINE, MEQUITAZINE, AND PLACEBO IN THE SYMPTOMATIC TREATMENT OF SEASONAL ALLERGIC RHINITIS

被引：38
|
作者：
SKASSABROCIEK, W
BOUSQUET, J
MONTES, F
VERDIER, M
SCHWAB, D
LHERMINIER, M
MICHEL, FB
机构：
[1] HOP AIGUELONGUE,MALAD RESP CLIN,F-34059 MONTPELLIER,FRANCE
[2] LABS UNICET,LEVALLOIS PERRET,FRANCE
来源：
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 1988年 / 81卷 / 04期
关键词：
D O I：
10.1016/0091-6749(88)91045-7
中图分类号：
R392 [医学免疫学];
学科分类号：
100102 ;
摘要：
引用
收藏
页码：725 / 730
页数：6
相关论文
共 50 条
  • [21] Efficacy and safety of ebastine 20 mg compared to loratadine 10 mg once daily in the treatment of seasonal allergic rhinitis: A randomized, double-blind, placebo-controlled study
    Ratner, P
    Hampel, F
    Van Bavel, J
    Howland, W
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2004, 133 (04) : 371 - 379
  • [22] ASTEMIZOLE IN PERENNIAL ALLERGIC RHINITIS WITH SEASONAL EXACERBATIONS - A PLACEBO-CONTROLLED DOUBLE-BLIND-STUDY
    TANAY, A
    NEUMAN, I
    ANNALS OF ALLERGY, 1989, 63 (06): : 493 - 494
  • [23] Concomitant montelukast and loratadine as treatment for seasonal allergic rhinitis: A randomized, placebo-controlled clinical trial
    Meltzer, EO
    Malmstrom, K
    Lu, S
    Prenner, BM
    Wei, LX
    Weinstein, SF
    Wolfe, JD
    Reiss, TF
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2000, 105 (05) : 917 - 922
  • [24] Montelukast for treating seasonal allergic rhinitis: a randomized, double-blind, placebo-controlled trial performed in the spring
    Philip, G
    Malmstrom, K
    Hampel, FC
    Weinstein, SF
    LaForce, CF
    Ratner, PH
    Malice, MP
    Reiss, TF
    CLINICAL AND EXPERIMENTAL ALLERGY, 2002, 32 (07): : 1020 - 1028
  • [25] Double-blind, placebo-controlled trial of reformulated azelastine nasal spray in patients with seasonal allergic rhinitis
    Bernstein, Jonathan A.
    Prenner, Bruce
    Ferguson, Berrylin J.
    Portnoy, Jay
    Wheeler, William J.
    Sacks, Harry J.
    AMERICAN JOURNAL OF RHINOLOGY & ALLERGY, 2009, 23 (05) : 512 - 517
  • [26] Reduction of eosinophil counts by montelukast in double-blind, randomized, placebo-controlled studies of seasonal allergic rhinitis
    Ritter, S
    Philip, G
    Hampel, FC
    Malmstrom, K
    Malice, MP
    Reiss, TF
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2002, 109 (01) : S240 - S240
  • [27] Efficacy and tolerability of montelukast alone or in combination with loratadine in seasonal allergic rhinitis: a multicenter, randomized, double-blind, placebo-controlled trial performed in the fall
    Nayak, AS
    Philip, G
    Lu, S
    Malice, MP
    Reiss, TF
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2002, 88 (06) : 592 - 600
  • [28] Double-Blind Placebo-Controlled Trial of Bepotastine Salicylate in Patients With Allergic Rhinitis
    Mo, Ji-Hun
    Jeong, Jin Hyeok
    Kim, Tae Hoon
    Kim, Seon-Tae
    Kim, Soo Whan
    Lee, Kun Hee
    Hong, Seung-No
    Kim, Hyo Yeol
    Kim, Dae Woo
    Kim, Dong-Young
    Kim, Chang-Hoon
    Cho, Seok Hyun
    Rhee, Chae-Seo
    LARYNGOSCOPE, 2021, 131 (03): : E702 - E709
  • [29] A Double-Blind, Randomized, Placebo-Controlled Trial of Acupuncture for the Treatment of Childhood Persistent Allergic Rhinitis
    Raymund Pothmann
    Daniel K. Ng
    Pok-yu Chow
    Shun-pei Ming
    Siu-hung Hong
    Sunny Lau
    Debbie Tse
    Handong Li
    Jackson C. Ho
    Wilson K. Kwong
    Mui-fong Wong
    Wilfred H. Wong
    Yu-ming Fu
    Ka-li Kwok
    Deutsche Zeitschrift für Akupunktur, 2008, 51 (1) : 54 - 55
  • [30] A double-blind, randomized, placebo-controlled trial of acupuncture for the treatment of childhood persistent allergic rhinitis
    Ng, DK
    Chow, PY
    Ming, SP
    Hong, SH
    Lau, S
    Tse, D
    Kwong, WK
    Wong, MF
    Wong, WH
    Fu, YM
    Kwok, KL
    Li, HD
    Ho, JC
    PEDIATRICS, 2004, 114 (05) : 1242 - 1247
12345